Publication Name	World Journal of Cardiology
Manuscript ID	100436
Country	China

Received	2024-08-16 11:32
Peer-Review Started	2024-08-16 11:32
To Make the First Decision
Return for Revision	2024-09-17 06:03
Revised	2024-09-29 01:54
Second Decision	2024-10-11 02:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-11 08:28
Articles in Press	2024-10-11 08:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-14 00:36
Publish the Manuscript Online	2024-10-17 14:39

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Letter to the Editor
Article Title	Effectiveness and mechanisms of sodium-dependent glucose transporter 2 inhibitors in type 2 diabetes and heart failure patients
Manuscript Source	Invited Manuscript
All Author List	Yan-Xi Zhang, Hai-Sheng Hu and Bao-Qing Sun
Funding Agency and Grant Number
Corresponding Author	Bao-Qing Sun, PhD, Professor, Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, No. 28 Qiaozhong Middle Road, Guangzhou 510120, Guangdong Province, China. sunbaoqing@vip.163.com
Key Words	Sodium-dependent glucose transporter inhibitors; Type 2 diabetes mellitus; Heart failure; Treatment; Cardiovascular disease
Core Tip	Studies have revealed that type 2 diabetes mellitus (T2DM) patients often suffer from multiple comorbidities that can be effectively treated with sodium-dependent glucose transporter inhibitors (SGLT2i), which has been linked to their anti-apoptotic properties, promotion of weight loss, and cardiovascular protection. Correctly avoiding the risks of SGLT2i use and aggressive use of the drug in patients with T2DM and its complications to alleviate symptoms are feasible.
Publish Date	2024-10-17 14:39
Citation	<p>Zhang YX, Hu HS, Sun BQ. Effectiveness and mechanisms of sodium-dependent glucose transporter 2 inhibitors in type 2 diabetes and heart failure patients. <i>World J Cardiol</i> 2024; 16(10): 611-615</p>
URL	https://www.wjgnet.com/1949-8462/full/v16/i10/611.htm
DOI	https://dx.doi.org/10.4330/wjc.v16.i10.611

Full Article (PDF)	WJC-16-611-with-cover.pdf
Manuscript File	100436_Auto_Edited_015953.docx
Answering Reviewers	100436-answering-reviewers.pdf
Audio Core Tip	100436-audio.mp3
Conflict-of-Interest Disclosure Form	100436-conflict-of-interest-statement.pdf
Copyright License Agreement	100436-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100436-non-native-speakers.pdf
Peer-review Report	100436-peer-reviews.pdf
Scientific Misconduct Check	100436-scientific-misconduct-check.png
Scientific Editor Work List	100436-scientific-editor-work-list.pdf
CrossCheck Report	100436-crosscheck-report.pdf